| 1. |
Bellani G, Laffey JG, Pham T, et al. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in Intensive Care Units in 50 countries. JAMA, 2016, 315(8): 788-800.
|
| 2. |
Gika H, Virgiliou C, Theodoridis G, et al. Untargeted LC/MS-based metabolic phenotyping (metabonomics/metabolomics): The state of the art. J Chromatogr B Analyt Technol Biomed Life Sci, 2019, 1117: 136-147.
|
| 3. |
Mandal R, Chamot D, Wishart DS. The role of the Human Metabolome Database in inborn errors of metabolism. J Inherit Metab Dis, 2018, 41(3): 329-336.
|
| 4. |
Fitzpatrick AM, Park Y, Brown LA, et al. Children with severe asthma have unique oxidative stress-associated metabolomic profiles. J Allergy Clin Immunol, 2014, 133(1): 258-261.e251-258.
|
| 5. |
Ubhi BK, Riley JH, Shaw PA, et al. Metabolic profiling detects biomarkers of protein degradation in COPD patients. Eur Respir J, 2012, 40(2): 345-355.
|
| 6. |
Tang YQ, Li Z, Lazar L, et al. Metabolomics workflow for lung cancer: Discovery of biomarkers. Clin Chim Acta, 2019, 495: 436-445.
|
| 7. |
Izquierdo-Garcia JL, Nin N, Jimenez-Clemente J, et al. Metabolomic profile of ARDS by nuclear magnetic resonance spectroscopy in patients with H1N1 influenza virus pneumonia. Shock, 2018, 50(5): 504-510.
|
| 8. |
Bowler RP, Jacobson S, Cruickshank C, et al. Plasma sphingolipids associated with chronic obstructive pulmonary disease phenotypes. Am J Respir Crit Care Med, 2015, 191(3): 275-284.
|
| 9. |
Robles AI, Harris CC. Integration of multiple "OMIC" biomarkers: A precision medicine strategy for lung cancer. Lung Cancer, 2017, 107: 50-58.
|
| 10. |
Laiakis EC, Morris GAJ, Fornace Jr AJ, et al. Metabolomic analysis in severe childhood pneumonia in the Gambia, West Africa: findings from a pilot study. PLoS One, 2010, 5(9): e12655.
|
| 11. |
Evans CR, Karnovsky A, Kovach MA, et al. Untargeted LC-MS metabolomics of bronchoalveolar lavage fluid differentiates acute respiratory distress syndrome from health. J Proteome Res, 2014, 13(2): 640-649.
|
| 12. |
Kapoor K, Singla E, Sahu B, et al. PARP inhibitor, olaparib ameliorates acute lung and kidney injury upon intratracheal administration of LPS in mice. Mol Cell Biochem, 2015, 400(1-2): 153-162.
|
| 13. |
Rai RK, Azim A, Sinha N, et al. Metabolic profiling in human lung injuries by high-resolution nuclear magnetic resonance spectroscopy of bronchoalveolar lavage fluid (BALF). Metabolomics, 2013, 9(3): 667-676.
|
| 14. |
Viswan A, Singh C, Rai RK, et al. Metabolomics based predictive biomarker model of ARDS: A systemic measure of clinical hypoxemia. PLoS One, 2017, 12(11): e0187545.
|
| 15. |
Bos LDJ, van Walree IC, Kolk AHJ, et al. Alterations in exhaled breath metabolite-mixtures in two rat models of lipopolysaccharide-induced lung injury. J Appl Physiol (1985), 2013, 115(10): 1487-1495.
|
| 16. |
Schubert JK, Muller WPE, Benzing A, et al. Application of a new method for analysis of exhaled gas in critically ill patients. Intensive Care Med, 1998, 24(5): 415-421.
|
| 17. |
King J, Mochalski P, Unterkofler K, et al. Breath isoprene: muscle dystrophy patients support the concept of a pool of isoprene in the periphery of the human body. Biochem Biophys Res Commun, 2012, 423(3): 526-530.
|
| 18. |
Bos LDJ, Weda H, Wang YY, et al. Exhaled breath metabolomics as a noninvasive diagnostic tool for acute respiratory distress syndrome. Eur Respir J, 2014, 44(1): 188-197.
|
| 19. |
Rogers AJ, Contrepois K, Wu M, et al. Profiling of ARDS pulmonary edema fluid identifies a metabolically distinct subset. Am J Physiol Lung Cell Mol Physiol, 2017, 312(5): L703-L709.
|
| 20. |
Calfee CS, Delucchi K, Parsons PE, et al. Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials. Lancet Respir Med, 2014, 2(8): 611-620.
|
| 21. |
Lin SH, Yue X, Wu H, et al. Explore potential plasma biomarkers of acute respiratory distress syndrome (ARDS) using GC-MS metabolomics analysis. Clin Biochem, 2019, 66: 49-56.
|
| 22. |
Kuo CD, Wu WG, Wang JH, et al. Proton nuclear magnetic resonance studies of plasma to determine metabolic status of patients with adult respiratory distress syndrome. Clin Chem, 1989, 35(4): 667-670.
|
| 23. |
Stringer KA, Serkova NJ, Karnovsky A, et al. Metabolic consequences of sepsis-induced acute lung injury revealed by plasma 1H-nuclear magnetic resonance quantitative metabolomics and computational analysis. Am J Physiol Lung Cell Mol Physiol, 2011, 300(1): L4-L11.
|
| 24. |
Singh C, Rai RK, Azim A, et al. Metabolic profiling of human lung injury by 1H high-resolution nuclear magnetic resonance spectroscopy of blood serum. Metabolomics, 2015, 11(1): 166-174.
|
| 25. |
Yoon MS. The emerging role of branched-chain amino acids in insulin resistance and metabolism. Nutrients, 2016, 8(7): E405.
|
| 26. |
Luo L, Shaver CM, Zhao ZG, et al. Clinical predictors of hospital mortality differ between direct and indirect ARDS. Chest, 2017, 151(4): 755-763.
|
| 27. |
Ferrarini A, Righetti L, Martínez MP, et al. Discriminant biomarkers of acute respiratory distress syndrome associated to H1N1 influenza identified by metabolomics HPLC-QTOF-MS/MS platform. Electrophoresis, 2017, 38(18): 2341-2348.
|
| 28. |
Metwaly S, Cote A, Donnelly SJ, et al. Evolution of ARDS biomarkers: Will metabolomics be the answer?. Am J Physiol Lung Cell Mol Physiol, 2018, 315(4): L526-L534.
|
1/5
WeChat